Brinkley Ruth Williams - 14 Sep 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role: Director
Signature: /s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol: TVTX
Transactions as of: 14 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2021, 18:16:01 UTC
Next filing: 12 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVTX	Common Stock	Award	$0	+5,250		$0.000000	5,250	14 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TVTX	Stock Option (Right to Buy)	Award	$0	+15,750		$0.000000	15,750	14 Sep 2021	Common Stock	15,750	$23.61	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter.